Lung cancer: open trials in South Korea

• NCT04198766

  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Trial Treatment · Phase 1/2 · Inhibrx Biosciences, Inc

  Inje University College of Medicine, Busan · Chungbuk National University Hospital, Cheongju-si · The Catholic University of Korea St. Vincent's Hospital, Gyeonggi-do · Chonnam National University Hwasun Hospital, Hwasun · Gachon University Gil Medical Center, Incheon · CHA Bundang Medical Center, Seongnam-si · Hanyang University Seoul Hospital, Seoul · Korea University Anam Hospital, Seoul · Asan Medical Center, Seoul · Korea University Guro Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Ajou University Hospital, Suwon

  Registry updated 2026-11-06

• NCT05384626

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  Trial Treatment · Phase 1/2 · Nuvalent Inc.

  National Cancer Center, Goyang-si · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-06

• NCT05920356

  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  Trial Treatment · Phase 3 · Amgen

  Pusan National University Hospital, Busan · National Cancer Center, Goyang-si Gyeonggi-do · Gachon University Gil Medical Center, Incheon · Asan Medical Center, Seoul · Korea University Anam Hospital, Seoul · Samsung Medical Center, Seoul · Korea University Guro Hospital, Seoul · Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnam-do

  Registry updated 2026-11-06

• NCT06881784

  Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  Trial Treatment · Phase 3 · Revolution Medicines, Inc.

  Chungbuk National University Hospital, Cheongju-si · Ajou University Hospital, Gyeonggi-do · Chonnam National University Hwasun Hospital, Hwasun · Samsung Medical Center, Seoul · Korea University Anam Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-06

• NCT06983743

  A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 1 · Erasca, Inc.

  Inje University Haeundae Paik Hospital Clinical Trial Center, Haeundae · Seoul St. Mary's Hospital Clinical Trial Center, Seoul

  Registry updated 2026-11-06

• NCT07699328

  A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer

  Trial Treatment · Phase 1/2 · Voronoi, Inc

  Chungbuk National University Hospital, Cheongju-si · Seoul National University Bundang Hospital, Seongnam-si · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon

  Registry updated 2026-11-06

• NCT07921888

  Patient-Specific MRD Liquid Biopsy in Resected NSCLC: Plasma and Bronchial Washing ctDNA

  Research · Eun Hye Lee

  Gangnam Severance Hospital, Seoul · Severance hospital, Seoul · Yongin Severance Hospital, Yongin-si

  Registry updated 2026-11-06

• NCT05789082

  A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

  Trial Treatment · Phase 1/2 · Hoffmann-La Roche

  Pusan National University Hospital, Busan · Korea University Guro Hospital, Seoul · Asan Medical Center, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-05

• NCT06586957

  A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  Trial Treatment · Phase 1 · NiKang Therapeutics, Inc.

  Chung-Ang University Gwangmyeong Hospital, Gwangmyeong · Yonsei Cancer Center / Severance Hospital, Seoul

  Registry updated 2026-11-05

• NCT06793215

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Pusan National University Hospital, Busan · Chungbuk National University Hospital, Cheongju-si · Kyungpook National University Chilgok Hospital, Daegu · Korea University Guro Hospital, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-05

• NCT07144280

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Pfizer

  Chungbuk National University Hospital, Cheongju-si · Boramae Medical Center, Dongjak-gu · National Cancer Center, Goyang-si · Inje University Haeundae Paik Hospital, Haeundae-gu · Seoul National University Bundang Hospital, Seongnam · CHA Bundang Medical Center, CHA University, Seongnam-si · Samsung Medical Center, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon

  Registry updated 2026-11-05

• NCT07361497

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Chungbuk National University Hospital, Cheongju-si · Seoul National University Bundang Hospital, Seongnam · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul

  Registry updated 2026-11-05

• NCT07519655

  Phase 1 Study of PF-08046033 in Advanced Solid Tumors

  Trial Treatment · Phase 1 · Pfizer

  Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-05

• NCT05579366

  Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  Trial Treatment · Phase 1/2 · Genmab

  Korea Institute of Radiological and Medical Sciences, Seoul

  Registry updated 2026-11-04

• NCT06119581

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Chungbuk National University Hospital, Cheongju-si · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Chilgok Hospital, Deagu · Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun · Severance Hospital, Yonsei University Health System, Seoul · Korea University Guro Hospital, Seoul · Samsung Medical Center, Seoul · Asan Medical Center, Seoul · The Catholic University of Korea Yeouido St. Mary's Hospital, Seoul · Korea University Anam Hospital, Seoul · Hanyang University Seoul Hospital, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon · Pusan National University Yangsan Hospital, Yangsan

  Registry updated 2026-11-04

• NCT06400472

  A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  Trial Treatment · Phase 1 · Eli Lilly and Company

  National Cancer Center, Goyang-si Gyeonggi-do

  Registry updated 2026-11-04

• NCT06452277

  A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 3 · Bayer

  Chungbuk National University Hospital | Hematology and Oncology, Chungcheongbuk-do · Chonnam National University Hwasun Hospital | Pulmonology and Critical Care Medicine, Hwasun-gun · Gyeongsang National University Hospital | Oncology, Jinju · Seoul National University Hospital | Oncology, Jongno -Gu · Samsung Medical Center | Oncology, Seoul · Severance Hospital | Oncology, Seoul · St Vincent's Hospital | Oncology, Suwon · Pusan National University Yangsan Hospital | Pulmonology, Yangsan

  Registry updated 2026-11-04

• NCT06465069

  A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  Trial Treatment · Phase 1 · Eli Lilly and Company

  Asan Medical Center, Seoul

  Registry updated 2026-11-04

• NCT06561685

  A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 1 · Eli Lilly and Company

  National Cancer Center, Ilsandong-gu · Severance Hospital, Yonsei University Health System, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon

  Registry updated 2026-11-04

• NCT06695845

  A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

  Trial Treatment · Phase 2 · Jazz Pharmaceuticals

  Samsung Medical Center, Gangnam-Gu · Korea University Guro Hospital, Guro-gu · Chonnam National University Hwasun Hospital, Hwasun-Eup · Seoul National University Hospital, Jongno-gu · Severance Hospital, Seodaemun-gu · Asan Medical Center, Seoul · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Seoul National University Bundang Hospital, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon · National Cancer Center Suwon, Suwon

  Registry updated 2026-11-04

• NCT06706076

  A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

  Trial Treatment · Phase 1/2 · BlossomHill Therapeutics

  Samsung Medical Center, Seoul · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul

  Registry updated 2026-11-04

• NCT06890598

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  Trial Treatment · Phase 3 · Eli Lilly and Company

  The Catholic University of Korea, Incheon St. Mary's Hospital, Bupyeong-gu · Pusan National University Hospital, Busan · Chungbuk National University Hospital, Cheongju-si · Keimyung University Dongsan Hospital, Daegu · Kyungpook National University Chilgok Hospital, Deagu · The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Eunpyeong-gu · Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu · National Cancer Center, Goyang-si · Chonnam National University Hwasun Hospital, Hwasun-gun · Yeungnam Univeristy Medical Center, Nam-gu · Seoul National University Bundang Hospital, Seongnam · Korea University Guro Hospital, Seoul · Konkuk University Medical Center, Seoul · The Catholic University of Korea Yeouido St. Mary's Hospital, Seoul · Asan Medical Center, Seoul · The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Samsung Medical Center, Seoul · The Catholic University of Korea St. Vincent's Hospital, Suwon · Pusan National University Yangsan Hospital, Yangsan

  Registry updated 2026-11-04

• NCT07423117

  A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

  Trial Treatment · Phase 1 · IntoCell, Inc

  Asan Medical Center, Seoul · Severance hospital, Seoul · Samsung Medical Center, Seoul

  Registry updated 2026-11-04

• NCT07492680

  A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  Trial Treatment · Phase 2 · Bristol-Myers Squibb

  Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Asan Medical Center, Seoul

  Registry updated 2026-11-04

• NCT05498428

  A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  Trial Treatment · Phase 2 · Janssen Research & Development, LLC

  National Cancer Center, Goyang-si · Seoul National University Bundang Hospital, Seongnam-si · Asan Medical Center, Seoul · Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-03

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error